Hwa Jung Sung

Clinical outcomes and prognostic factors in patients with breast diffuse large B cell lymphoma; Consortium for Improving Survival of Lymphoma (CISL) study

Ho‐Young Yhim, Hye Jin Kang, Yoon Hee Choi et al. · BMC Cancer · 2010 · 80 citations · Full text

Treatment outcome of front-line systemic chemotherapy for localized extranodal NK/T cell lymphoma in nasal and upper aerodigestive tract

Seok Jin Kim, Byung Soo Kim, Chul Won Choi et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2006 · 44 citations

Early lymphopenia as a risk factor for chemotherapy‐induced febrile neutropenia

Chul Won Choi, Hwa Jung Sung, Kyong Hwa Park et al. · American Journal of Hematology · 2003 · 43 citations · Full text

Epidemiology Of Cancer, Immunology, Pathology +19

Stemness Evaluation of Mesenchymal Stem Cells from Placentas According to Developmental Stage: Comparison to Those from Adult Bone Marrow

Hwa Jung Sung, Soon–Cheol Hong, Ji Hyun Yoo et al. · Journal of Korean Medical Science · 2010 · 36 citations · Full text

Telomerase Activity, Adult Stem Cell, Stem Cell Biology +21

Increased Serum 90K and Galectin-3 Expression Are Associated with Advanced Stage and a Worse Prognosis in Diffuse Large B-Cell Lymphomas

Seok Jin Kim, Seung Jin Lee, Hwa Jung Sung et al. · Acta Haematologica · 2008 · 36 citations